These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20470945)

  • 1. Can proton pump inhibitors accentuate skin aging?
    Namazi MR; Jowkar F
    Arch Med Res; 2010 Feb; 41(2):147-8. PubMed ID: 20470945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
    Tanaka H; Yamaba H; Kosugi N; Mizutani H; Nakata S
    Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S57-64. PubMed ID: 18060420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
    Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
    J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors: predisposers to Alzheimer disease?
    Fallahzadeh MK; Borhani Haghighi A; Namazi MR
    J Clin Pharm Ther; 2010 Apr; 35(2):125-6. PubMed ID: 20456731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors: actions and reactions.
    Mullin JM; Gabello M; Murray LJ; Farrell CP; Bellows J; Wolov KR; Kearney KR; Rudolph D; Thornton JJ
    Drug Discov Today; 2009 Jul; 14(13-14):647-60. PubMed ID: 19443264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging of the skin connective tissue: how to measure the biochemical and mechanical properties of aging dermis.
    Oikarinen A
    Photodermatol Photoimmunol Photomed; 1994 Apr; 10(2):47-52. PubMed ID: 8043384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of elastin and collagen in cutaneous aging: intrinsic aging versus photoexposure.
    Uitto J
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s12-6. PubMed ID: 18404866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
    Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
    J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
    Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
    Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors and pain.
    Smith HS; Dhingra R; Ryckewaert L; Bonner D
    Pain Physician; 2009; 12(6):1013-23. PubMed ID: 19935988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors: the beginning of the end or the end of the beginning?
    Scarpignato C; Hunt RH
    Curr Opin Pharmacol; 2008 Dec; 8(6):677-84. PubMed ID: 18840545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in skin aging and photoaging.
    Chung JH; Eun HC
    J Dermatol; 2007 Sep; 34(9):593-600. PubMed ID: 17727362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl oxidase in development, aging and pathologies of the skin.
    Szauter KM; Cao T; Boyd CD; Csiszar K
    Pathol Biol (Paris); 2005 Sep; 53(7):448-56. PubMed ID: 16085123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interaction between clopidogrel and proton pump inhibitors.
    Khalique SC; Cheng-Lai A
    Cardiol Rev; 2009; 17(4):198-200. PubMed ID: 19525682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.